VEGFA and neoplasm: While VEGF was found to inhibit PKA activation in vivo and in primary cells derived from the tumor site, when the same assay was performed in cultured human umbilical cord endothelial cells, VEGF had the opposite effect on PKA activity, highlighting the importance of assays being performed in the appropriate cell context.